Login
Toggle navigation
Videos
Categories
Trending
Robert LoCascio, CEO of LivePerson, revealed a business strategy secret during his Mobile World Congress interview.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
John has served as LivePerson's CEO since January 2024.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
7 Essential Tips for Securing a Mortgage and Buying a Home
00:10:00
DIA Metals Expands Portfolio with Niobium and Titanium Projects for the Green Economy
00:10:00
Investing in seed stage founders working on emerging areas of technology, specifically, blockchains, virtual reality|Anjney Midha,Founder,KPCB Edge
00:10:00
Exploring Coast FIRE: Financial Independence with Flexibility
00:10:00
Sondrel (Holdings) PLC's founder and CEO Graham Curren discusses the company's AIM listing with Proactive.
00:00:00
Why Mayo Clinic for Cancer Treatment - Mayo Clinic/ Sameer R. Keole, M.D. Radiation Oncologist, mayo Clinic
00:10:00
TAURON Polska Energia SA's Strong First Quarter Performance | Marek Wadowski, Vice-President ,Tauron Polska Energia SA.
00:10:00
Achieve Financial Independence with the Path to Prosperity Process
00:00:00
Digitization and Decentralization of Clinical Trials - Dr. David Harmon, a Cardiology Fellow, both at Mayo Clinic
00:10:00
Learning Technologies Group's Jonathan Satchell and Tharisa PLC CEO discuss the company's solid Q2 performance and innovative energy storage solution.
00:10:00
Gain valuable insights into the strategic initiatives, innovative projects, and future prospects of Hecla Mining Company|Phillips S. Baker, Jr,President and CEO of Hecla Mining Company
00:00:00
Regeneus ASX:RGS May 2021 Business Update - Karolis Rosickas, CEO, Regeneus Ltd